Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt No Debt
CUTR's Cash to Debt is ranked higher than
99% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 2.26 vs. CUTR: No Debt )
CUTR' s 10-Year Cash to Debt Range
Min: No Debt   Max: No Debt
Current: No Debt

Equity to Asset 0.74
CUTR's Equity to Asset is ranked higher than
78% of the 470 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. CUTR: 0.74 )
CUTR' s 10-Year Equity to Asset Range
Min: -0.27   Max: 0.87
Current: 0.74

-0.27
0.87
Interest Coverage No Debt
CUTR's Interest Coverage is ranked higher than
70% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 436.41 vs. CUTR: No Debt )
CUTR' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 3
Z-Score: 5.31
M-Score: -2.85
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -13.59
CUTR's Operating margin (%) is ranked higher than
60% of the 486 Companies
in the Global Medical Devices industry.

( Industry Median: 4.88 vs. CUTR: -13.59 )
CUTR' s 10-Year Operating margin (%) Range
Min: -20.83   Max: 22.05
Current: -13.59

-20.83
22.05
Net-margin (%) -13.58
CUTR's Net-margin (%) is ranked higher than
61% of the 486 Companies
in the Global Medical Devices industry.

( Industry Median: 2.74 vs. CUTR: -13.58 )
CUTR' s 10-Year Net-margin (%) Range
Min: -32.93   Max: 18.25
Current: -13.58

-32.93
18.25
ROE (%) -12.92
CUTR's ROE (%) is ranked higher than
60% of the 477 Companies
in the Global Medical Devices industry.

( Industry Median: 3.43 vs. CUTR: -12.92 )
CUTR' s 10-Year ROE (%) Range
Min: -16.6   Max: 56.57
Current: -12.92

-16.6
56.57
ROA (%) -9.87
CUTR's ROA (%) is ranked higher than
62% of the 513 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. CUTR: -9.87 )
CUTR' s 10-Year ROA (%) Range
Min: -13.66   Max: 23.97
Current: -9.87

-13.66
23.97
ROC (Joel Greenblatt) (%) -434.81
CUTR's ROC (Joel Greenblatt) (%) is ranked higher than
53% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 5.54 vs. CUTR: -434.81 )
CUTR' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1247.08   Max: 312.88
Current: -434.81

-1247.08
312.88
Revenue Growth (3Y)(%) 7.80
CUTR's Revenue Growth (3Y)(%) is ranked higher than
81% of the 347 Companies
in the Global Medical Devices industry.

( Industry Median: 4.20 vs. CUTR: 7.80 )
CUTR' s 10-Year Revenue Growth (3Y)(%) Range
Min: -18.1   Max: 54.9
Current: 7.8

-18.1
54.9
EBITDA Growth (3Y)(%) -2.90
CUTR's EBITDA Growth (3Y)(%) is ranked higher than
73% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. CUTR: -2.90 )
CUTR' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -29.5   Max: 89.8
Current: -2.9

-29.5
89.8
EPS Growth (3Y)(%) 0.50
CUTR's EPS Growth (3Y)(%) is ranked higher than
76% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: -1.70 vs. CUTR: 0.50 )
CUTR' s 10-Year EPS Growth (3Y)(%) Range
Min: -29.8   Max: 159.6
Current: 0.5

-29.8
159.6
» CUTR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

CUTR Guru Trades in Q1 2014

Jim Simons 779,202 sh (New)
Jim Simons 714,000 sh (+15.12%)
Charles Brandes 32,675 sh (+2.14%)
Mario Gabelli 650,000 sh (-4.41%)
» More
Q2 2014

CUTR Guru Trades in Q2 2014

Jim Simons 793,500 sh (+11.13%)
Mario Gabelli 650,000 sh (unchged)
Charles Brandes 31,935 sh (-2.26%)
» More
Q3 2014

CUTR Guru Trades in Q3 2014

Mario Gabelli 650,000 sh (unchged)
Charles Brandes 30,805 sh (-3.54%)
Jim Simons 757,900 sh (-4.49%)
» More
Q4 2014

CUTR Guru Trades in Q4 2014

Jim Simons 779,202 sh (+2.81%)
Mario Gabelli 650,000 sh (unchged)
Charles Brandes 30,040 sh (-2.48%)
» More
» Details

Insider Trades

Latest Guru Trades with CUTR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
Forward P/E 46.51
CUTR's Forward P/E is ranked higher than
73% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. CUTR: 46.51 )
N/A
P/B 2.50
CUTR's P/B is ranked higher than
78% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 4.48 vs. CUTR: 2.50 )
CUTR' s 10-Year P/B Range
Min: 0.68   Max: 5.31
Current: 2.5

0.68
5.31
P/S 2.50
CUTR's P/S is ranked higher than
70% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 4.21 vs. CUTR: 2.50 )
CUTR' s 10-Year P/S Range
Min: 0.93   Max: 7.8
Current: 2.5

0.93
7.8
EV-to-EBIT -11.11
CUTR's EV-to-EBIT is ranked lower than
53% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. CUTR: -11.11 )
CUTR' s 10-Year EV-to-EBIT Range
Min: -242.1   Max: 695.7
Current: -11.11

-242.1
695.7
Current Ratio 4.56
CUTR's Current Ratio is ranked higher than
82% of the 505 Companies
in the Global Medical Devices industry.

( Industry Median: 2.67 vs. CUTR: 4.56 )
CUTR' s 10-Year Current Ratio Range
Min: 2.62   Max: 9.09
Current: 4.56

2.62
9.09
Quick Ratio 4.08
CUTR's Quick Ratio is ranked higher than
84% of the 505 Companies
in the Global Medical Devices industry.

( Industry Median: 1.98 vs. CUTR: 4.08 )
CUTR' s 10-Year Quick Ratio Range
Min: 2.37   Max: 8.66
Current: 4.08

2.37
8.66
Days Inventory 106.61
CUTR's Days Inventory is ranked higher than
84% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 174.47 vs. CUTR: 106.61 )
CUTR' s 10-Year Days Inventory Range
Min: 24.95   Max: 137.01
Current: 106.61

24.95
137.01
Days Sales Outstanding 52.02
CUTR's Days Sales Outstanding is ranked higher than
88% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 83.34 vs. CUTR: 52.02 )
CUTR' s 10-Year Days Sales Outstanding Range
Min: 22.62   Max: 70.94
Current: 52.02

22.62
70.94

Valuation & Return

vs
industry
vs
history
Price/Net Cash 3.80
CUTR's Price/Net Cash is ranked higher than
97% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. CUTR: 3.80 )
CUTR' s 10-Year Price/Net Cash Range
Min: 1.44   Max: 4.1
Current: 3.8

1.44
4.1
Price/Net Current Asset Value 3.00
CUTR's Price/Net Current Asset Value is ranked higher than
97% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. CUTR: 3.00 )
CUTR' s 10-Year Price/Net Current Asset Value Range
Min: 1.2   Max: 3.26
Current: 3

1.2
3.26
Price/Tangible Book 2.60
CUTR's Price/Tangible Book is ranked higher than
86% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 8.40 vs. CUTR: 2.60 )
CUTR' s 10-Year Price/Tangible Book Range
Min: 0.77   Max: 20.59
Current: 2.6

0.77
20.59
Price/DCF (Projected) 6.60
CUTR's Price/DCF (Projected) is ranked higher than
79% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. CUTR: 6.60 )
CUTR' s 10-Year Price/DCF (Projected) Range
Min: 0.6   Max: 5.06
Current: 6.6

0.6
5.06
Price/Median PS Value 1.20
CUTR's Price/Median PS Value is ranked higher than
71% of the 576 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. CUTR: 1.20 )
CUTR' s 10-Year Price/Median PS Value Range
Min: 0.66   Max: 2.33
Current: 1.2

0.66
2.33
Earnings Yield (Greenblatt) -8.80
CUTR's Earnings Yield (Greenblatt) is ranked higher than
50% of the 492 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. CUTR: -8.80 )
CUTR' s 10-Year Earnings Yield (Greenblatt) Range
Min: -8.8   Max: 795.7
Current: -8.8

-8.8
795.7

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:TJ9.Germany,
Cutera Inc was established in the San Francisco Bay Area in 1998. It is a medical device company, specializing in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners. It offers easy-to-use products based on four main platforms/systems Xeo, GenesisPlus, ExcelV, and truSculpt, each of which enables physicians and other qualified practitioners to perform safe and effective aesthetic procedures for their customers. The Xeo is a multi-application platform on which a customer can purchase hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, improving texture, reducing pore size, and treating fine lines and laxity. GenesisPlus platform, is a dedicated laser system for performing aesthetic skin procedures and for the temporary increase of clear nail in patients with onychomycosis, or toenail fungus. ExcelV is a high-performance, vascular platform designed specifically for the core-market of Dermatologists and Plastic Surgeons. This platform provides a combination of the 532 nm green laser with Cutera's award-winning 1064 nm Nd:YAG technology, to provide a single, compact and efficient system that treats the entire range of cosmetic vascular conditions, without the need for costly consumables. truSculpt is a high-powered radio frequency platform designed for the non-invasive body contouring market. This system is designed to treat all body areas and with its electrode design is able to achieve comfortable, uniform heating of the subcutaneous fat. In the U.S. its markets and sells its products mainly through a direct sales organization. International sales are generally made through a distributor network in over 60 countries. As of December 31, 2013, the Company had 30 issued U.S. patents and 11 pending U.S. patent applications. Its registered trademarks include Cutera, Acutip 500, CoolGlide, CoolGlide Excel, Limelight, myQ, Pearl, ProWave 770, ProWave LX, Solera, Titan, Xeo and truSculpt. The Company's products competes against laser and other energy-based products offered by public companies, such as Cynosure, Elen (in Italy), Lumenis, Syneron and Zeltiq, as well as private companies, including, Alma, Sciton, and several others. Its products are medical devices subject to extensive and rigorous regulation by the U.S. Food and Drug Administration, as well as other regulatory bodies.
» More Articles for CUTR

Headlines

Articles On GuruFocus.com
Chuck Royce's Top Five Second Quarter Portfolio Increases Aug 07 2013 
Gurus Buy Micro Caps – Bamboo Toilet Paper Jul 24 2013 
Guru Weekly Real Time Update Jul 05 2013 
Mario Gabelli and Jean-Marie Eveillard's Real Time Increases Jul 02 2013 
Weekly CFO Sells Highlight: MSCC, BMRN, VAL, CUTR, REX, CIEN Oct 02 2011 
Comment for Benjamin Graham Net Current Asset Value Screener Jun 03 2011 

More From Other Websites
CUTERA INC Financials Mar 21 2015
Cutera Announces Korean Clearance of enlighten(TM) Mar 20 2015
CUTERA INC Files SEC form 10-K, Annual Report Mar 16 2015
Cutera(R) Expands Its Stock Repurchase Program to $40 Million Feb 27 2015
Cutera to Present at the 27th Annual Roth Conference Feb 25 2015
Cutera Reports Fourth Quarter 2014 Results Feb 18 2015
Cutera(R) Expands Its Stock Repurchase Program to $40 Million Feb 18 2015
CUTERA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 18 2015
Cutera reports 4Q loss Feb 05 2015
Cutera reports 4Q loss Feb 05 2015
Cutera Inc Earnings Call scheduled for 5:00 pm ET today Feb 05 2015
CUTERA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Feb 05 2015
Cutera Reports Fourth Quarter 2014 Results Feb 05 2015
Q4 2014 Cutera Inc Earnings Release - After Market Close Feb 05 2015
[$$] Aesthetic-Laser Stocks Focus on More Upside Jan 30 2015
Cutera, Inc. to Announce Results for the Fourth Quarter Ended December 31, 2014 Jan 29 2015
Updated Earnings Release Date -- Cutera, Inc. to Announce Results for the Fourth Quarter Ended... Jan 29 2015
Cutera, Inc. to Announce Results for the Fourth Quarter Ended December 31, 2014 Jan 26 2015
CUTERA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and... Jan 08 2015
Cutera Announces Preliminary Revenue for Fourth Quarter 2014 Jan 06 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK